Abstract
A diagnosis of new-onset diabetes after transplantation (NODAT) is a common complication after kidney transplantation. Most importantly, NODAT affects graft and patient survival, and increases the incidence of post-transplant cardiovascular disease. In this review paper, non-modifiable and modifiable risk factors for NODAT are discussed. In addition, pre-transplant evaluation and post-transplant monitoring of glucose and management of immunosuppression are discussed. If early detection of risk factor for new-onset diabetes, the timely prevention and clinical management, reduce complications, it will help to improve the long-term survival after kidney transplantation.
Translated title of the contribution | New-Onset Diabetes after Kidney Transplantation |
---|---|
Original language | Chinese (Traditional) |
Pages (from-to) | 76-79 |
Number of pages | 4 |
Journal | 腎臟與透析 |
Volume | 28 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2016 |
Externally published | Yes |